2891.20
-1.14%
Axis Direct
We maintain our HOLD rating with a target price of Rs 1,580, implying an upside potential of 4%, valuing the company at a PE of 20x for FY27.
Gland Pharma has gained 11.93% in the last 1 Week
More from Gland Pharma Ltd.
Recommended